ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
4.150
-0.015 (-0.36%)
At close: Sep 17, 2026, 4:00 PM EDT
4.170
+0.020 (0.48%)
After-hours: Sep 17, 2026, 7:40 PM EDT
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $412.71 million as of September 17, 2026. Its market cap has decreased by -55.62% in one year.
Market Cap
412.71M
Enterprise Value
440.46M
1-Year Change
-55.62%
Ranking
Category
Stock Price
$4.15
ChartMarket Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has decreased from $568.25M to $412.71M, a decrease of -27.37%. That is a compound annual growth rate of -7.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 412.71M | -64.16% |
| Dec 31, 2025 | 1.15B | 12.32% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
| Nov 9, 2022 | 568.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cabaletta Bio | 439.97M |
| Artiva Biotherapeutics | 435.61M |
| Rezolute | 433.54M |
| Kyverna Therapeutics | 430.43M |
| Prothena Corporation | 427.64M |
| C4 Therapeutics | 421.98M |
| Inhibikase Therapeutics | 420.59M |
| Atea Pharmaceuticals | 419.47M |